BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30230914)

  • 21. Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells.
    Li ZY; Huang GD; Chen L; Zhang C; Chen BD; Li QZ; Wang X; Zhang XJ; Li WP
    Mol Med Rep; 2017 Nov; 16(5):5908-5914. PubMed ID: 28849207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β1 accelerates the DNA damage response in epithelial cells via Smad signaling.
    Lee J; Kim MR; Kim HJ; An YS; Yi JY
    Biochem Biophys Res Commun; 2016 Aug; 476(4):420-425. PubMed ID: 27237972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.
    Guan F; Kang Z; Wang L; Wang K; Mao BB; Peng WC; Zhang BL; Lin ZY; Zhang JT; Hu ZQ
    Chin Med J (Engl); 2019 Oct; 132(20):2430-2437. PubMed ID: 31613821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer.
    Zhang B; Halder SK; Zhang S; Datta PK
    Cancer Lett; 2009 May; 277(1):114-20. PubMed ID: 19147275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.
    Zhang C; Zhang X; Xu R; Huang B; Chen AJ; Li C; Wang J; Li XG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):162. PubMed ID: 29145888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
    Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
    J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
    Jiang X; Zhou T; Wang Z; Qi B; Xia H
    ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment.
    Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β.
    Luangmonkong T; Suriguga S; Adhyatmika A; Adlia A; Oosterhuis D; Suthisisang C; de Jong KP; Mutsaers HAM; Olinga P
    Toxicol Appl Pharmacol; 2018 Sep; 355():127-137. PubMed ID: 30008374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
    Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
    Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
    Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting methylguanine-DNA methyltransferase in the treatment of neuroblastoma.
    Wagner LM; McLendon RE; Yoon KJ; Weiss BD; Billups CA; Danks MK
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5418-25. PubMed ID: 17875772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro.
    Boeckmann L; Thoms KM; Gutzmer R; Has C; Kunz M; Kuschal C; Laspe P; Struever D; Emmert S
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):33-5. PubMed ID: 19203531
    [No Abstract]   [Full Text] [Related]  

  • 35. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo.
    Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B
    Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of MEN1 gene in radiation-induced pulmonary fibrosis in mice.
    Wei W; Zhang HY; Gong XK; Dong Z; Chen ZY; Wang R; Yi JX; Shen YN; Jin SZ
    Gene; 2018 Dec; 678():252-260. PubMed ID: 30099020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetic analysis for malignant gliomas: clinical implications and future directions].
    Mizoguchi M; Shono T
    No Shinkei Geka; 2008 Jan; 36(1):83-91. PubMed ID: 18232326
    [No Abstract]   [Full Text] [Related]  

  • 38. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
    Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
    Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
    Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.